Advertisement

Topics

Wistar Advancing Synthetic DNA Antibody-Based Therapy to Protect Against Zika

09:40 EST 1 Dec 2016 | Virgo Publishing

The Wistar Institute announces that the Bill & Melinda Gates Foundation has awarded an $8,777,578 million grant to the Wistar Institute to create a preventive Zika therapy utilizing synthetic DNA monoclonal antibodies (dMAbs). The goal of this Gates Foundation-funded program is to move this new technology to clinical study for protection

Original Article: Wistar Advancing Synthetic DNA Antibody-Based Therapy to Protect Against Zika

NEXT ARTICLE

More From BioPortfolio on "Wistar Advancing Synthetic DNA Antibody-Based Therapy to Protect Against Zika"

Quick Search
Advertisement
 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...